As mass spectrometry makes inroads into pathogen identification in the clinical laboratory, deep sequencing—even nanopore sequencing—is waiting in the wings. Jeffrey L. Fox investigates.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Doughty, E.L. et al. PeerJ 2, e585 (2014).
Wilson, M.R. et al. N. Engl. J. Med. 370, 2408–2417 (2014).
Loman, N.J. et al. J. Am. Med. Assoc. 309, 1502–1510 (2013).
Conlan, S. et al. Sci. Transl. Med. 6, 254ra126 (2014).
FDA Public Workshop. Advancing Regulatory Science for High Throughput Sequencing Devices for Microbial Identification and Detection of Antimicrobial Resistance Markers. Silver Spring, Maryland, April 1, 2014.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fox, J. Technology comes to typing. Nat Biotechnol 32, 1081–1084 (2014). https://doi.org/10.1038/nbt.3067
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3067